Shoulder Pericapsular Block Versus Interscalene Block in Arthroscopic Shoulder Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorMarmara University

About this trial

This randomized controlled trial aims to compare the incidence of hemidiaphragmatic paralysis (HDP) following ultrasound-guided interscalene block (ISB) versus shoulder pericapsular nerve group (PENG) block in patients undergoing elective shoulder surgery under general anesthesia.

The primary objective is to determine whether the shoulder PENG block reduces the incidence of HDP compared with conventional intrafascial ISB. HDP will be assessed using ultrasound measurement of diaphragmatic excursion 30 minutes after block performance

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

ASA physical status I-III

Scheduled for elective shoulder surgery under general anesthesia

Able to provide informed consent

Disqualifiers

Pre-existing diaphragmatic dysfunction

Severe COPD or restrictive pulmonary disease

Neuromuscular disorders

BMI > 40 kg/m²

Trial design

Design model

Parallel

Treatments tested in this trial

  • Interscalene Nerve Block

    Other intervention

    Procedure: Ultrasound-guided conventional intrafascial interscalene block at C5-C6 level Drug: 15 mL of 0.25% bupivacaine (37.5 mg)

  • shoulder pericapsular nerve group block

    Other intervention

    Procedure: Ultrasound-guided shoulder pericapsular nerve group block Drug: 15 mL of 0.25% bupivacaine (37.5 mg)

Treatment groups

70 Participants
are divided into 2 treatment groups
Group A: Shoulder PENG BlockActive comparator 1 intervention
Group B: Interscalene Block (ISB)Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

Hemidiaphragmatic Paralysis (HDP)

≥25% reduction in diaphragmatic excursion from baseline measured by ultrasound M-mode.

Time frame
30 minutes after block performance

Secondary outcomes

1

Complete hemidiaphragmatic paralysis (≥75% reduction or paradoxical motion)

≥75% reduction or paradoxical motion

Time frame
30 minutes after block performance
2

Absolute and percentage change in diaphragmatic excursion

change in diaphragmatic excursion

Time frame
30 minutes after block performance
3

Total 24-hour tramadol consumption (mg)

Total 24-hour tramadol consumption (mg)

Time frame
postoperative 24 hours
4

NRS pain scores (from 0 to 10: 0 stands for no pain, 10 stands for severe pain)

Postoperative pain scores

Time frame
postopertaive 2 hours, 6 hours, 12 hours, 24 hours

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.